163 related articles for article (PubMed ID: 3059252)
41. Acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Wang CY; Schroeter AL; Su WP
Mayo Clin Proc; 1995 Sep; 70(9):869-79. PubMed ID: 7643641
[TBL] [Abstract][Full Text] [Related]
42. Kaposi's sarcoma of the oral cavity: case reports.
Markopoulos AK; Papanayotou P; Trigonidis G
Quintessence Int; 1994 Jun; 25(6):415-8. PubMed ID: 7938430
[TBL] [Abstract][Full Text] [Related]
43. Kaposi's sarcoma associated with AIDS.
Stănescu L; Foarfă C; Georgescu AC; Georgescu I
Rom J Morphol Embryol; 2007; 48(2):181-7. PubMed ID: 17641807
[TBL] [Abstract][Full Text] [Related]
44. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
Flaitz CM; Nichols CM; Hicks MJ
Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
[TBL] [Abstract][Full Text] [Related]
45. Aetiology of Kaposi's sarcoma: current understanding and implications for therapy.
Boshoff C; Weiss RA
Mol Med Today; 1997 Nov; 3(11):488-94. PubMed ID: 9430784
[TBL] [Abstract][Full Text] [Related]
46. Overview of the management of AIDS-related Kaposi's sarcoma.
Morris AK; Valley AW
Ann Pharmacother; 1996 Oct; 30(10):1150-63. PubMed ID: 8893123
[TBL] [Abstract][Full Text] [Related]
47. Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS).
Tabata M; Langford A; Becker J; Reichart PA
Eur J Cancer B Oral Oncol; 1993 Jul; 29B(3):209-13. PubMed ID: 7905311
[TBL] [Abstract][Full Text] [Related]
48. Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome.
Ognibene FP; Steis RG; Macher AM; Liotta L; Gelmann E; Pass HI; Lane HC; Fauci AS; Parrillo JE; Masur H
Ann Intern Med; 1985 Apr; 102(4):471-5. PubMed ID: 3977195
[TBL] [Abstract][Full Text] [Related]
49. Classic Kaposi's sarcoma presenting in the oral cavity of two HIV-negative Quechua patients.
Mohanna S; Bravo F; Ferrufino JC; Sanchez J; Gotuzzo E
Med Oral Patol Oral Cir Bucal; 2007 Sep; 12(5):E365-8. PubMed ID: 17767100
[TBL] [Abstract][Full Text] [Related]
50. Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma: clinical, histological and cell biological evaluation.
Stürzl M; Zietz C; Eisenburg B; Goebel FD; Gillitzer R; Hofschneider PH; Bogner JR
Res Virol; 1994; 145(3-4):261-9. PubMed ID: 7800953
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
52. Clinical aspects of Kaposi's sarcoma.
Buchbinder A; Friedman-Kien AE
Curr Opin Oncol; 1992 Oct; 4(5):867-74. PubMed ID: 1457502
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic challenges of oral and cutaneous Kaposi's sarcoma in resource-constrained settings.
Speicher DJ; Wanzala P; D'Lima M; Njiru A; Chindia M; Dimba E; Johnson NW
J Oral Pathol Med; 2015 Nov; 44(10):842-9. PubMed ID: 25782476
[TBL] [Abstract][Full Text] [Related]
54. Regression of oral Kaposi's sarcoma in a case of AIDS on zidovudine (AZT).
Langford A; Ruf B; Kunze R; Pohle HD; Reichart P
Br J Dermatol; 1989 May; 120(5):709-13. PubMed ID: 2527052
[TBL] [Abstract][Full Text] [Related]
55. Noncytotoxic approaches to the treatment of HIV-associated Kaposi's sarcoma.
Pluda JM; Parkinson DR; Feigal E; Yarchoan R
Oncology (Williston Park); 1993 Dec; 7(12):25-33; discussion 33, 37-8. PubMed ID: 8292505
[TBL] [Abstract][Full Text] [Related]
56. [Pulmonary Kaposi's sarcoma in a patient with the acquired immunodeficiency syndrome].
Takechi A; Kashiyama T; Fuyama M; Kimura J
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):231-5. PubMed ID: 9103865
[TBL] [Abstract][Full Text] [Related]
57. [The clinico-pathogenetic characteristics of Kaposi's sarcoma].
Rytik PG; Khmara ME; Protas II; Nedz'ved' MK
Klin Med (Mosk); 1992 Jan; 70(1):19-23. PubMed ID: 1608201
[TBL] [Abstract][Full Text] [Related]
58. Clinical presentation and natural history of AIDS--related Kaposi's sarcoma.
Dezube BJ
Hematol Oncol Clin North Am; 1996 Oct; 10(5):1023-9. PubMed ID: 8880194
[TBL] [Abstract][Full Text] [Related]
59. Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related Kaposi's sarcoma.
Sulis E; Floris C; Sulis ML; Zurrida S; Piro S; Pintus A; Contu L
Eur J Cancer Clin Oncol; 1989 Apr; 25(4):759-61. PubMed ID: 2714351
[No Abstract] [Full Text] [Related]
60. [Kaposi's sarcoma: epidemiological, clinical, anatomopathological and therapeutic features in 75 patients].
Zaraa I; Labbene I; El Guellali N; Ben Alaya N; Mokni M; Ben Osman A
Tunis Med; 2012 Feb; 90(2):116-21. PubMed ID: 22407622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
